Invex
IXC.AXInvex Therapeutics Ltd Price (IXC.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
75,312,339
(0.2109)%Cash Flow Statement
Invex Therapeutics LtdCurrency: AUD
| YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -232,122.00
+0% |
-3,360,279.00
+1,348% |
-2,283,911.00
-32% |
-3,953,140.00
+73% |
-7,749,856.00
+96% |
-1,641,809.00
-79% |
|||||||||||||
| Depreciation And Amortiz... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Stock-Based Compensat... | 0.00 | 983.39k | 562.72k | 352.39k | 480.54k | 0.00 | |||||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | -18,510.00 | 36.49k | 95.68k | -124,517.00 | -187,852.00 | 0.00 | |||||||||||||
| Accounts Payables | 20.50k | 624.98k | -54,330.00 | 345.60k | 568.16k | -1,140,718.00 | |||||||||||||
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Other Working Capital | 0.00 | 0.00 | 54.33k | -345,601.00 | -568,158.00 | 0.00 | |||||||||||||
| Other Non-Cash Items | -1,990.00 | 112.03k | -52,739.00 | 348.56k | 588.03k | -802,204.00 | |||||||||||||
| Net Cash Provided By Op... | -230,132.00
+0% |
-1,603,393.00
+597% |
-1,678,245.00
+5% |
-3,376,709.00
+101% |
-6,869,139.00
+103% |
-2,444,013.00
-64% |
|||||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -8,191.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Acquisitions Net | -24,573.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Other Investing Activities | 24.57k | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Net Cash Used For Inv... | -8,191.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
|||||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Common Stock Issued | 12.41M | 14.43M | 8.65M | 0.00 | 0.00 | 0.00 | |||||||||||||
| Common Stock Repurch... | 0.00 | -1,818,947.00 | -553,670.00 | 0.00 | 0.00 | -14,001,162.00 | |||||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Other Financing Activities | 37.23M | 1.30M | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Net Cash Used/Provide... | 12.41M
+0% |
15.73M
+27% |
8.09M
-49% |
0.00
+0% |
0.00
+0% |
-14,001,162.00
+0% |
|||||||||||||
| Effect Of Forex Changes... | 24.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Net Change In Cash | 36.51M | 14.13M | 6.42M | -3,376,709.00 | -6,869,139.00 | -16,445,175.00 | |||||||||||||
| Cash At Beginning Of Per... | -24,340,494.00 | 12.17M | 26.30M | 32.72M | 29.34M | 22.47M | |||||||||||||
| Cash At End Of Period | 12.17M | 26.30M | 32.72M | 29.34M | 22.47M | 6.03M | |||||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | -230,132.00 | -1,603,393.00 | -1,678,245.00 | -3,376,709.00 | -6,869,139.00 | -2,444,013.00 | |||||||||||||
| Capital Expenditure | -8,191.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Free Cash Flow | -238,323.00
+0% |
-1,603,393.00
+573% |
-1,678,245.00
+5% |
-3,376,709.00
+101% |
-6,869,139.00
+103% |
-2,444,013.00
-64% |
|||||||||||||